SCHEMBL7965439

SCHEMBL7965439

CCN(CCOC(C)=O)c1ncnc2c1c(SC)nn2-c1c(Cl)cc(C(F)(F)F)cc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRP O00591 17/20 0.47
GABRD O14764 17/20 0.47
GABRA1 P14867 17/20 0.47
GABRB1 P18505 17/20 0.47
GABRG2 P18507 17/20 0.47
GABRB3 P28472 17/20 0.47
GABRA5 P31644 17/20 0.47
GABRA3 P34903 17/20 0.47
GABRA2 P47869 17/20 0.47
GABRB2 P47870 17/20 0.47
GABRA4 P48169 17/20 0.47
GABRE P78334 17/20 0.47
GABRA6 Q16445 17/20 0.47
GABRG1 Q8N1C3 17/20 0.47
GABRG3 Q99928 17/20 0.47
GABRQ Q9UN88 17/20 0.47
CDK4 P11802 2/20 0.45
CCND1 P24385 2/20 0.45
CCNE2 O96020 2/20 0.38
CCNE1 P24864 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL7965435 0.88 GABRP (0.46) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL7961966 0.76 CDK4 (0.59) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL7953286 0.71 CDK4 (0.46) CDK4CCND1CCNE2CCNE1CDK2
SCHEMBL7577957 0.68 CRHR1 (0.54) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL7969123 0.66 CDK4 (0.67) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL7962198 0.65 CDK4 (0.50) CDK4CCND1CCNE2CCNE1CDK2
SCHEMBL6928418 0.65 GABRP (1.00) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL7961465 0.65 CRHR1 (0.48) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL7965698 0.65 CDK4 (0.47) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL7962588 0.64 CDK4 (0.62) CDK4CCND1CCNE2CCNE1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218397-B1 FOR THERAPY OF STRESS-RELATED ILLNESSES, SUCH AS STRESS-INDUCED DEPRESSION, ANXIETY, AND HEADACHE; ABDOMINAL BOWEL SYNDROME; INFLAMMATORY DISEASES; IMMUNE SUPPRESSION; ALZHEIMER'S DISEASE; GASTRONINTESTINAL DISEASES PFIZER INC 2001-04-17 US disclosed
EP-0674642-B1 PYRAZOLOPYRIMIDINES AS CRF ANTAGONISTS PFIZER (US) 2000-08-23 EP disclosed
WO-1994013677-A1 PYRAZOLOPYRIMIDINES AS CRF ANTAGONISTS PFIZER INC. (US) 1994-06-23 WO disclosed